Doylestown, PA, United States of America

Roy E Twyman

USPTO Granted Patents = 12 



Average Co-Inventor Count = 4.3

ph-index = 5

Forward Citations = 118(Granted Patents)


Location History:

  • Sandy, UT (US) (1998)
  • Doylestown, PA (US) (2000 - 2024)

Company Filing History:


Years Active: 1998-2024

Loading Chart...
Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents

Title: The Innovative Journey of Roy E. Twyman in Pharmaceutical Inventions

Introduction: Roy E. Twyman, based in Doylestown, PA, is an accomplished inventor known for his significant contributions to the pharmaceutical industry. With a total of 12 patents to his name, his innovations focus primarily on the modulation of metabotropic glutamatergic receptor subtype 2, showcasing his expertise in pharmacology and neurology.

Latest Patents: Among his latest inventions are combinations that involve positive allosteric modulators (PAMs) of the metabotropic glutamatergic receptor subtype 2 (mGluR2). These patents detail compositions that may involve pharmaceutical salts or solvates and a synaptic vesicle protein 2A (SV2A) ligand, reflecting a promising avenue for therapeutic development in neurological disorders.

Career Highlights: Throughout his career, Roy E. Twyman has collaborated with prominent organizations like Ortho-McNeil Pharmaceutical Corporation and Janssen Pharmaceutica NV. His work has centered around advancing pharmaceutical strategies, and his inventions have the potential to enhance treatment options for various medical conditions.

Collaborations: Twyman's impressive network includes esteemed colleagues such as Carlos Plata-Salaman and Boyu Zhao. Together, they have contributed to the development of innovative therapeutic modalities, further emphasizing the collaborative nature of scientific advancement.

Conclusion: Roy E. Twyman’s contributions to the field of pharmaceuticals are marked by his significant patents and collaborations. His work continues to influence the development of innovative treatments, making strides in the understanding and application of metabotropic glutamatergic receptors in medicine. As his journey unfolds, the impact of his inventions promises to resonate within the pharmaceutical community for years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…